APPLIED GENETIC TECHNOLOGIES CORP AGTC Cash Flow

Applied genetic technologies corp (AGTC)

CashFlow / Quarterly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13
Operating activities:
Net income (loss)
-11,189	-8,623	-11,577	-10,514	11,489	-4,181	1,200	-6,612	-8,101	-5,190	-1,397	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net income (loss)
-	-	-	-	-	-	-	-	-	-	-	-	-1,199	1,779	3,025	2,728	1,969	3,045	-9,123	-7,961	-6,326	-4,650	-5,381	-4,521	-3,588	-735	-7,064
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Share-based compensation expense
874	689	810	909	845	1,094	1,181	1,121	1,272	1,331	1,469	1,445	1,249	1,492	1,420	1,402	1,116	1,366	1,123	700	892	821	407	625	89	77	34
Share-based collaboration expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	636	-	-	-	-	-	-	-	-
Depreciation and amortization
270	327	322	316	318	318	321	354	277	310	234	255	223	233	201	192	179	99	97	97	95	95	89	92	81	82	79
Recovery of bad debts
-	-	-	-100	0	111	-369	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Investment discount accretion
28	105	173	212	225	211	142	89	-31	-61	-82	-82	-104	-16	-200	-	-	-	-	-	-	-	-	-	-	-	-
Non-cash lease expense
-	74	71	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Non-cash interest on lease liabilities
-	118	122	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Equity in net losses of an affiliate
-11	-6	-10	-6	-10	-11	-8	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Fair value adjustments
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	336	-35	140
Changes in operating assets and liabilities:
Grants receivable
-	-	-	-113	-90	8	9	77	-70	21	8	5	91	44	-920	-57	115	-522	55	-	-	-	-	123	-3	194	29
Prepaid and other assets
949	-61	-228	-1,333	-11	432	-723	-43	199	1,739	8	-485	1,281	-74	-482	504	182	-4,962	5,838	131	406	-657	-141	-612	1,052	672	239
Deferred revenues
-	-	-	1	-20,433	-4,993	-2,967	-2,195	-2,845	-3,735	-9,754	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accounts payable
1,162	375	66	-178	-214	-1,365	2,084	-377	286	-1,432	1,470	181	100	-365	-249	-154	668	-6,794	6,420	413	247	-542	110	-305	421	-277	317
Operating lease liabilities
82	-270	-271	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Increase (decrease) in deferred revenues
-	-	-	-	-	-	-	-	-	-	-	-7,795	-7,907	-10,803	-11,725	-11,725	-11,724	-11,724	98,837	-	-	-	-	0	0	-146	-66
Accrued and other liabilities
943	1,380	-323	789	1,165	97	-1,447	961	1,538	566	-739	-1,491	583	625	-69	446	-54	-191	2,862	423	821	29	593	664	109	547	-94
Net cash used in operating activities
-8,818	-8,321	-10,715	-7,537	-6,944	-9,559	583	-6,743	-7,277	-9,849	-8,651	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Investing activities:
Net cash (used in) operating activities
-	-	-	-	-	-	-	-	-	-	-	-	-8,219	-6,993	-5,795	-7,399	-7,854	-8,715	94,959	-6,409	-4,961	-4,074	-4,041	-2,890	-3,601	-3,480	-1,957
Purchases of property and equipment
378	190	244	82	0	40	41	8	520	4	130	179	-3	542	21	-	-	-	-	0	45	133	47	69	35	50	4
Purchases of and capitalized costs related to intangible assets
92	139	118	0	80	45	23	-	-	-	-	20	40	43	49	16	20	30	55	30	11	27	30	105	26	12	75
Maturities of investments
23,000	23,000	17,500	22,500	25,000	21,883	24,736	12,717	29,895	31,481	26,807	22,423	16,552	28,911	35,358	78,544	11,080	7,314	13,030	12,949	19,680	40,000	48,450	-	-	-	-
Maturity of short-term investments
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	5,000
Purchases of investments
4,519	12,535	16,874	9,915	20,343	14,801	29,722	-	-	-	-	17,025	13,298	34,819	2,400	59,961	27,591	94,556	26,072	11,806	14,488	38,412	38,158	55,450	4,000	16,500	4,000
Net cash provided by investing activities
14,011	10,136	264	12,503	4,577	6,997	-5,050	-9,735	-15,404	31,477	26,677	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Financing activities:
Proceeds from the issuance of common stock, net of issuance costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	19,211	0	0	-30	32,039	-	-	-	-
Proceeds from exercises of common stock options
-	-	-	-	-	-	-	-	-	-	-	-	-	5	19	-	-	-	-	-	-	-	-	-	-	-	-
Net cash provided by investing activities
-	-	-	-	-	-	-	-	-	-	-	-	1,217	-6,493	32,888	18,335	-18,664	-87,378	-13,097	1,113	5,136	1,428	10,215	-48,124	2,439	-6,062	921
Proceeds from exercise of common stock options
-	0	34	-	-	-	-	-	-	1	2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Taxes paid related to equity awards
0	0	3	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred offering costs
-	-	-	-	0	55	113	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Payments made toward finance lease liability
-	11	11	-	-	13	13	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from exercise of convertible preferred stock warrants
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1
Payment of bank term notes and capital lease
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1
Net cash (used in) provided by financing activities
-	-	-	-	-	-	-	-	-	-	-	-	3	5	19	48	0	235	19,211	0	79	39	32,039	-	-	-	-
Net cash provided by (used in) financing activities
35,222	-11	20	167	-41	68	-126	-90	-31	-17	2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net increase (decrease) in cash and cash equivalents
40,415	1,804	-10,431	5,133	-2,408	-2,494	-4,593	-16,568	-22,712	21,611	18,028	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Supplemental information:
Net increase(decrease) in cash and cash equivalents
-	-	-	-	-	-	-	-	-	-	-	-4,794	-6,999	-13,481	27,112	10,984	-26,518	-95,858	101,073	-5,296	254	-2,607	38,213	593	-968	1,141	-1,036
Cash paid during the year for income taxes
-	-	-	-	-	-	-	-53	0	0	670	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash paid for interest
-	2	2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost related to purchase of intellectual property included in accrued and other liabilities
-	-	32	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Shares issued for no consideration
0	0	3	-	7	13	8	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-